Keyphrases
T Cells
58%
T Cell Receptor
46%
Tumor
26%
Neoantigen
24%
Metastatic Melanoma
21%
Human Leukocyte Antigen
19%
Adoptive Cell Therapy
19%
Formin
18%
Genetically Modified T Cells
17%
Tumor Rejection
16%
Melanoma
16%
T Cell Receptor Transgenic T Cells
16%
T Cell Response
14%
Specific T Cells
13%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
13%
Nivolumab
13%
Mass Spectrometry
13%
Adoptive Transfer
13%
Programmed Death-ligand 1 (PD-L1)
13%
In Cancer
12%
Transgenic
12%
Derived Peptide
12%
Chimeric Antigen Receptor T Cells (CAR-T)
11%
Clinical Translation
11%
Tumor Cells
11%
Immunopeptidomics
10%
Epitope
9%
Peptide Ligand
9%
Clinical Application
9%
Pembrolizumab
9%
Cell-based
9%
HLA-A*02
9%
Target Antigen
9%
T Cell Repertoire
9%
Neoantigen Identification
9%
Ipilimumab
9%
Treatment Options
8%
Anti-programmed Cell death-1 Therapy
8%
Peripheral Blood Stem Cells
8%
Cryopreservation
8%
PD-1 Blockade
8%
Preclinical Modeling
8%
Molecular Modeling
8%
Clinical Outcomes
8%
Leukocytes
8%
Deep Learning
8%
Carboxypeptidase G2
8%
Advanced Melanoma
8%
Poloxamer
8%
Cancer Immunotherapy
8%
Immunology and Microbiology
T Cell
100%
T Cell Receptor
62%
Peptides
49%
Immunotherapy
32%
Transgenics
31%
Neoantigen
23%
Human Leukocyte Antigen
22%
Intravenous Immunoglobulin
17%
Immunity
13%
Cytotoxic T Cell
13%
Epitope
12%
Cytotoxic T-Cell
11%
Stem Cell
10%
Tumor Cell
10%
Immunopeptidomics
10%
Antigen Specificity
10%
Positron Emission Tomography
10%
Immune Response
9%
Tumor Antigen
9%
Leukemia Cell
9%
Tumor Rejection
8%
Peripheral Blood Stem Cell
8%
Lentivirus Vector
8%
Cryopreservation
8%
Multiple Myeloma
8%
Cancer Immunotherapy
8%
Allogeneic Stem Cell Transplantation
7%
Vesiculovirus
7%
Hematopoietic Cell
6%
Programmed Death-Ligand 1
6%
Cytotoxicity
6%
MHC Class II
6%
T-Helper Cell
6%
Proteomics
6%
Virus
5%
Myeloid
5%
B Cell Maturation Antigen
5%
Lentivirus
5%
Myeloperoxidase
5%
Allogeneic Hematopoietic Stem Cell Transplantation
5%
Amino Terminal Sequence
5%
Antineoplastic Activity
5%
Chimeric Antigen Receptor T-Cell
5%
Memory T Cell
5%
Medicine and Dentistry
T Cell
70%
T Lymphocyte Receptor
35%
Neoplasm
34%
Immunotherapy
22%
In Vitro
14%
Cell Therapy
14%
Metastatic Melanoma
14%
Cytotoxic T-Cell
13%
Side Effect
13%
Melanoma
12%
Immunoglobulin
12%
Leukemia Cell
12%
Malignant Neoplasm
11%
B-Cell Chronic Lymphocytic Leukemia
11%
T Cell Receptor
11%
T-Cell Response
10%
Antigen Specificity
10%
Peripheral Blood Stem Cell
9%
Chimeric Antigen Receptor
9%
Tumor Cell
8%
Multiple Myeloma
8%
HLA-A
8%
Cryopreservation
8%
Polyethylene Terephthalate
8%
Diseases
8%
Programmed Death-Ligand 1
7%
Nivolumab
7%
Solid Malignant Neoplasm
7%
Immunity
7%
Lymphocyte
7%
Positron Emission Tomography
7%
Adoptive Transfer
6%
Ewing Sarcoma
6%
Vesiculovirus
6%
CTLA-4
6%
Human Leukocyte Antigen
6%
Combination Therapy
6%
Oncology
6%
Stem Cell
5%
Cancer
5%
B Cell Maturation Antigen
5%
Tumor Antigen
5%
Clinical Trial
5%
Programmed Death 1 Receptor
5%
Allogeneic Stem Cell Transplantation
5%
Virotherapy
5%
Methenamine
5%
Antineoplastic Activity
5%
